Market Cap

Renalytix AI plc Market Capitalization:

£25.8 Million

GBP as of Jan. 1, 2026

US$34.7 Million

business Renalytix AI plc Company Profile

Renalytix AI plc Main Stock Listing

LSE: RENX

Market Capitalization History of Renalytix AI plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $222.61 B
Danaher $164.98 B
Siemens Healthineers AG $57.84 B
IDEXX Laboratories, Inc. $53.62 B
Lonza Group Ltd $47.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Renalytix AI plc market cap

Date Market Cap YoY Change
Jan. 1, 2026 £25.8 M -32.79%
Jan. 1, 2025 £38.4 M 132.66%
Jan. 1, 2024 £16.5 M -77.98%
Jan. 1, 2023 £74.9 M -79.17%
Jan. 1, 2022 £359.5 M -48.66%
Jan. 1, 2021 £700.2 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Renalytix AI plc Categories

United Kingdom languages Healthcare languages Diagnostics & Research
United Kingdom Healthcare United Kingdom Diagnostics & Research

Stocks & Indices

Renalytix AI plc has the following listings and related stock indices.


Stock: LSE: RENX

Stock: NASDAQ: RNLX

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.